WRND
NYLI Global Equity R&D Leaders ETF
Price Chart
Latest Quote
$42.38
+0.00 (+0.00%)
Current Price
| Previous Close | $42.38 |
| Open | $41.51 |
| Day High | $42.38 |
| Day Low | $42.38 |
| Volume | 4 |
Fund Information
| Quarterly Dividend / Yield | N/A / 0.91% |
| Net Assets | $10.85M |
| Expense Ratio | 0.18% |
| Category | Global Large-Stock Growth |
| Fund Family | New York Life Investment Management LLC |
| Net Asset Value | $41.47 |
| Premium/Discount | 2.20% |
| Quarterly Dividend Yield | 0.91% |
| P/E Ratio | 25.65 |
| Exchange | NGM |
š ETF Analysis
Company Data
Financial Ratios
Returns & Margins
Ownership
| Insider & Institutional transactions data not available |
Valuation Ratios
Analyst Data
Technical Indicators
| SMA20 | $42.95 |
| SMA50 | $42.89 |
| SMA200 | $40.59 |
| RSI | 33.94 |
| ATR | 0.5179 |
| Rel Volume | 0.03 |
Performance History
| Week | +0.03% |
| Month | -2.88% |
| Quarter | +6.62% |
| 6 Months | +4.99% |
| YTD | +13.71% |
| Year | +14.62% |
| 3 Years | +87.75% |
| 10 Years | +80.71% |
ETF Scoring Not Available
Exchange-traded funds (ETFs) are not scored using our fundamental analysis metrics, as they represent baskets of securities rather than individual companies.
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-10-27 | $42.11 | 10 |
| 2026-10-26 | $41.51 | 100 |
| 2026-10-23 | $41.20 | 200 |
| 2026-10-22 | $41.22 | 100 |
| 2026-10-21 | $42.53 | 200 |
| 2026-10-20 | $42.09 | 700 |
| 2026-10-19 | $42.15 | 100 |
| 2026-10-16 | $41.72 | 200 |
| 2026-10-15 | $42.78 | 100 |
| 2026-10-14 | $42.65 | 100 |
| 2026-10-13 | $43.58 | 100 |
| 2026-10-12 | $43.71 | 100 |
| 2026-10-09 | $44.01 | 100 |
| 2026-10-08 | $43.61 | 200 |
| 2026-10-07 | $44.31 | 100 |
| 2026-10-06 | $44.63 | 2,600 |
| 2026-10-05 | $44.43 | 100 |
| 2026-10-02 | $44.05 | 900 |
| 2026-10-01 | $43.37 | 100 |
| 2026-09-30 | $43.41 | 100 |
| 2026-09-29 | $43.51 | 100 |
| 2026-09-28 | $43.36 | 1,600 |
About NYLI Global Equity R&D Leaders ETF
The underlying index seeks to provide exposure to innovative companies by investing in the equities of companies around the world whose research and development (āR&Dā) spending indicates a commitment to innovation and a focus on long-term growth. The fund will, under normal circumstances, invest at least 80% of its assets (net assets plus the amount of any borrowings for investment purposes) in equity securities determined to be R&D Leaders. The fund is non-diversified.
š° Latest News
No news articles available at the moment. Check back later for updates on WRND.
Period:
Loading...
No financial data available yet. Financial data will be fetched automatically.